Ankara City Hospital
Ankara, 06800, Turkey (Türkiye)
NCT Number: NCT06137443
The goal of this clinical trial is to compare the effects of balance therapy with an overground gait trainer in incomplete spinal cord injury (SCI). The main questions it aims to answer are:
* Is balance therapy with an overground gait trainer effective in improving functional ambulation in SCI? * Is balance therapy with an overground gait trainer effective in enhancing Activities of Daily Living in SCI?
Participants treated with either:
• Overground gait trainer along with conventional exercise therapy
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Ankara, 06800, Turkey (Türkiye)
Background: Spinal Cord Injury (SCI) and similar pathologies not only negatively affect a person's ability to walk but also have adverse effects on their participation in social, vocational, and recreational activities. The correction of walking impairments resulting from SCI is one of the most important goals of rehabilitation, as it is essential for a person's social and vocational integration. When considering balance function, the use of challenging balance and walking exercises at an adequate level is necessary to trigger motor learning. Ensuring the patient's safety is the primary priority when using advanced balance and walking exercises based on the patient's current condition. In this study, Andago V2.0 (Hocoma AG, Volketswil, Switzerland) has been preferred for ensuring safety by adapting to patient movements. The main objective of the study was to assess the impact of Andago on balance in patients with motor incomplete SCI. The secondary aim was to evaluate its influence on quality of life and independence. Methods: The study included five participants who were over 18 years of age and had experienced a spinal injury within the past year. These participants were classified as AIS D (American Spinal Injury Association Impairment Scale). Patients underwent eight-week treatment, with walking and balance exercises on Andago performed three days a week. In addition, conventional in-bed exercises, including stretching, strengthening, and mobility exercises, were administered for 40 minutes, two days a week. Modified Borg Scale (MBS), Ten-Meter Walking Test (10MWT), Timed Up and Go Test (TUG), Walking Index in Spinal Cord Injury II (WISCI II), Berg Balance Scale (BBS), Visual Analogue Scale (VAS) for fear of falling, Spinal Cord Independence Measure (SCIM III), World Health Organization Quality of Life Scale-Short Form (WHOQOL - BREF) were used for evaluation.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients underwent treatment for eight weeks, with walking and balance exercises on Andago performed three days a week. In addition, conventional in-bed exercises, including stretching, strengthening, and mobility exercises, were administered for 40 minutes, two days a week.
Time frame: 11 months
Berg Balance Scale for balance assessment
Time frame: 11 months
Ten-Meter Walking Test for overground walking speed assessment
Time frame: 11 months
Timed Up and Go Test overground walking assessment
Time frame: 11 months
Walking Index in Spinal Cord Injury II for walking independence level assessment
Time frame: 11 months
Modified Borg Scale for subjective fatigue assessment
Time frame: 11 months
Visual Analogue Scale (VAS) for fear of falling assessment
Time frame: 11 months
Spinal Cord Independence Measure (SCIM III) for activity of daily living assessment
Time frame: 11 months
World Health Organization Quality of Life Scale-Short Form (WHOQOL - BREF) for quality of life assessment
Ankara City Hospital Bilkent
Other
Enhancing Balance and Mobility in Incomplete Spinal Cord Injury With an Overground Gait Trainer
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06137456
Central Nervous System Diseases, Mobility Limitation
Ankara, Turkey (Türkiye)
View Trial DetailsNCT04460872
Androgen Deficiency, Bone Diseases
Gainesville, Florida, United States
View Trial DetailsNCT05473676
Brain Damage, Chronic, Brain Diseases
Calgary, Alberta, Canada
View Trial DetailsNCT07705906
Brain Diseases, Cardiovascular Diseases
Dhaka, Dhaka Division, Bangladesh
View Trial Details